Keywords: allergan, licenses, polyphor, pem, drugs, 61m, deal

Allergan licenses Polyphor's PEM drugs in $61M deal

Article | 10 November 2008

Privately-held Swiss firm Polyphor has licensed the rights to develop Protein Epitope Mimetics cytokine inhibitors for conditions and diseases of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Allergan

Go to company listing